Optimising survival in malignant mesothelioma
Author:
- 1 August 2007
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 57, S24-S29
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Malignant Pleural Mesothelioma: A Comprehensive ReviewCancer Control, 2006
- Soluble Mesothelin–Related Peptides in the Diagnosis of Malignant Pleural MesotheliomaAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Asbestos Exposure, Pleural Mesothelioma, and Serum Osteopontin LevelsNew England Journal of Medicine, 2005
- Correlation of Osteopontin Protein Expression and Pathological Stage across a Wide Variety of Tumor HistologiesClinical Cancer Research, 2004
- Factors Predictive of Survival Among 337 Patients With Mesothelioma Treated Between 1984 and 1994 by the Cancer and Leukemia Group BChest, 1998
- Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.Journal of Clinical Oncology, 1998
- A Proposed New International TNM Staging System for Malignant Pleural MesotheliomaChest, 1995
- Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 2: Prognosis and stagingCancer, 1993
- Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.Journal of Clinical Oncology, 1993
- Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.Thorax, 1976